Your browser doesn't support javascript.
loading
Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis.
Åkefeldt, Selma Olsson; Ismail, Mohamad Bachar; Belot, Alexandre; Salvatore, Giulia; Bissay, Nathalie; Gavhed, Désirée; Aricò, Maurizio; Henter, Jan-Inge; Valentin, Hélène; Delprat, Christine.
Afiliação
  • Åkefeldt SO; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
  • Ismail MB; Astrid Lindgren Children's Hospital, Karolinska University Hospital, Stockholm, Sweden.
  • Belot A; UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Salvatore G; UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Bissay N; Laboratoire Microbiologie Santé et Environnement, Doctoral School of Sciences and Technology, Faculty of Public Health, Lebanese University, Tripoli, Lebanon.
  • Gavhed D; Faculty of Science, Lebanese University, Tripoli, Lebanon.
  • Aricò M; UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
  • Henter JI; Centre International de Recherche en Infectiologie (CIRI), Univ Lyon, Inserm, U1111, Université Claude Bernard, Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
  • Valentin H; Pediatric Nephrology, Rheumatology, Dermatology Unit, HFME, Hospices Civils de Lyon, Bron, France.
  • Delprat C; UnivLyon, Université Claude Bernard Lyon 1, Villeurbanne, France.
Front Oncol ; 11: 780191, 2021.
Article em En | MEDLINE | ID: mdl-35127485

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suécia